Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Chronic tubulointerstitial kidney disease in untreated adenine phosphoribosyl transferase (APRT) deficiency: A case report

B Cochran, T Kovacikova, K Hodanova, M Zivna, A Hnizda, AG Niehaus, A Bonnecaze, G Balasubraminiam, I Ceballos-Picot, A Hawfield, K Kidd, S Kmoch, AJ Bleyer

. 2018 ; 90 (4) : 296-301.

Jazyk angličtina Země Německo

Perzistentní odkaz   https://www.medvik.cz/link/bmc22008253

Grantová podpora
NV17-29786A MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek

E-zdroje Online Plný text

NLK ProQuest Central od 2016-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2016-01-01 do Před 1 rokem

Odkazy

PubMed 30106368
DOI 10.5414/cn109460
Knihovny.cz E-zdroje

Adenine phosphoribosyltransferase (APRT) deficiency (OMIM #614723) is a rare autosomal recessive defect in the purine salvage pathway that causes excessive production of 2,8-dihydroxyadenine, leading to nephrolithiasis and chronic kidney disease (CKD). This case report describes the natural history of CKD in untreated APRT deficiency. We describe a novel APRT mutation (chr16:88877985 G / C; c.195 C>/G; p.His54Asp) presenting with CKD without nephrolithiasis. The patient initially required dialysis, but kidney function improved with allopurinol. We reviewed APRT deficiency reported in the literature to determine the loss of kidney function in individuals with untreated APRT deficiency and its relationship to nephrolithiasis. We identified 95 individuals in whom kidney function was assessed prior to treatment. There was a bimodal distribution of kidney failure. AKI occurred frequently in childhood due to obstructing nephrolithiasis or crystalline nephropathy and was usually reversible. CKD developed after age 20 in all patients irrespective of nephrolithiasis history, with 36/42 patients > 40 years of age having at least stage 3 CKD, and 24/42 having an eGFR > 10 mL/min/1.73m2 or being on dialysis. There were 13 adults without nephrolithiasis and 50 adults with nephrolithiasis. The mean age of end-stage renal diesease (ESRD) was 50.52 +/- 13.9 for those without nephrolithiasis and 43.4 +/- 15.8 years for those with nephrolithiasis (p = 0.24). APRT deficiency is associated with slowly progressive CKD that occurs independently of nephrolithiasis. Diagnosis should be considered in all individuals with chronic tubulointerstitial kidney disease, with or without the presence of nephrolithiasis. In our patient, allopurinol 300 mg/day resulted in improvement of kidney function..

000      
00000naa a2200000 a 4500
001      
bmc22008253
003      
CZ-PrNML
005      
20220404150606.0
007      
ta
008      
220317s2018 gw f 000 0|eng||
009      
AR
024    7_
$a 10.5414/CN109460 $2 doi
035    __
$a (PubMed)30106368
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Cochran, Benjamin $u Department of Internal Medicine, Mayo Clinic College of Medicine and Science, Jacksonville, FL, USA
245    10
$a Chronic tubulointerstitial kidney disease in untreated adenine phosphoribosyl transferase (APRT) deficiency: A case report / $c B Cochran, T Kovacikova, K Hodanova, M Zivna, A Hnizda, AG Niehaus, A Bonnecaze, G Balasubraminiam, I Ceballos-Picot, A Hawfield, K Kidd, S Kmoch, AJ Bleyer
520    9_
$a Adenine phosphoribosyltransferase (APRT) deficiency (OMIM #614723) is a rare autosomal recessive defect in the purine salvage pathway that causes excessive production of 2,8-dihydroxyadenine, leading to nephrolithiasis and chronic kidney disease (CKD). This case report describes the natural history of CKD in untreated APRT deficiency. We describe a novel APRT mutation (chr16:88877985 G / C; c.195 C>/G; p.His54Asp) presenting with CKD without nephrolithiasis. The patient initially required dialysis, but kidney function improved with allopurinol. We reviewed APRT deficiency reported in the literature to determine the loss of kidney function in individuals with untreated APRT deficiency and its relationship to nephrolithiasis. We identified 95 individuals in whom kidney function was assessed prior to treatment. There was a bimodal distribution of kidney failure. AKI occurred frequently in childhood due to obstructing nephrolithiasis or crystalline nephropathy and was usually reversible. CKD developed after age 20 in all patients irrespective of nephrolithiasis history, with 36/42 patients > 40 years of age having at least stage 3 CKD, and 24/42 having an eGFR > 10 mL/min/1.73m2 or being on dialysis. There were 13 adults without nephrolithiasis and 50 adults with nephrolithiasis. The mean age of end-stage renal diesease (ESRD) was 50.52 +/- 13.9 for those without nephrolithiasis and 43.4 +/- 15.8 years for those with nephrolithiasis (p = 0.24). APRT deficiency is associated with slowly progressive CKD that occurs independently of nephrolithiasis. Diagnosis should be considered in all individuals with chronic tubulointerstitial kidney disease, with or without the presence of nephrolithiasis. In our patient, allopurinol 300 mg/day resulted in improvement of kidney function..
650    17
$a adeninfosforibosyltransferasa $x nedostatek $7 D000228 $2 czmesh
650    07
$a alopurinol $x terapeutické užití $7 D000493 $2 czmesh
650    07
$a antimetabolity $x terapeutické užití $7 D000963 $2 czmesh
650    07
$a hodnoty glomerulární filtrace $7 D005919 $2 czmesh
650    07
$a lidé $7 D006801 $2 czmesh
650    17
$a ledvinové kameny $x etiologie $7 D007669 $2 czmesh
650    07
$a mužské pohlaví $7 D008297 $2 czmesh
650    17
$a vrozené poruchy metabolismu $x komplikace $7 D008661 $2 czmesh
650    07
$a lidé středního věku $7 D008875 $2 czmesh
650    07
$a intersticiální nefritida $x etiologie $x komplikace $7 D009395 $2 czmesh
650    17
$a chronická renální insuficience $x etiologie $7 D051436 $2 czmesh
650    17
$a urolitiáza $x komplikace $7 D052878 $2 czmesh
700    1_
$a Kovačíková, Tereza $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hodaňová, Kateřina $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Živná, Martina $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hnízda, Aleš $u Department of Biochemistry, University of Cambridge, Cambridge, UK
700    1_
$a Niehaus, Angela G. $u Department of Pathology
700    1_
$a Bonnecaze, Alex $u Section on Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
700    1_
$a Balasubraminiam, Gowrie $u Department of Renal Medicine, Southend University Hospital, Prittlewell Chase, Westcliff-on-Sea, Southend, UK
700    1_
$a Ceballos-Picot. Irene $u Laboratoire de Biochimie Métabolique Hôpital Necker-Enfants Malades Paris, University Paris, Paris, France
700    1_
$a Hawfield, Amret $u Section on Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
700    1_
$a Kidd, Kendrah $u Section on Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
700    1_
$a Kmoch, Stanislav $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Section on Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
700    1_
$a Bleyer, Anthony J. $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Section on Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
773    0_
$t Clinical Nephrology $x 0301-0430 $g Roč. 90, č. 4 (2018), s. 296-301 $p Clin Nephrol $w MED00001143
773    0_
$p Clin Nephrol $g 90(4):296-301, 2018 Oct $x 0301-0430
910    __
$a ABA008 $y p $z 0
990    __
$a 20220317094950 $b ABA008
991    __
$a 20220404150604 $b ABA008
999    __
$a ok $b bmc $g 1770958 $s 1159447
BAS    __
$a 3
BMC    __
$a 2018 $b 90 $c 4 $d 296-301 $x MED00001143 $i 0301-0430 $m Clinical nephrology
GRA    __
$a NV17-29786A $p MZ0
LZP    __
$a 2021-granty

Najít záznam

Citační ukazatele

Možnosti archivace